L'influence du capital marque sur le risque perçu de la substitution d'un médicament de marque par un médicament générique : proposition d'un modèle

Abstract : Face generics laboratories that develop important communication campaigns to increase brand awareness and build a reputation, innovative laboratories are experiencing growing difficulties to extend the life of their original drugs. In this context, brands' equity (brand of innovative drug vs brand of generic) may be considered as a moderator of the risk perceived face of substitution. Based on a review of the literature on the determinants to the purchase of generic drugs and a qualitative study among patients-consumers, we propose a model integrating the comparison of the brands' equity as a moderating variable of the risk perceived towards substitution
Document type :
Conference papers
Complete list of metadatas

Cited literature [54 references]  Display  Hide  Download

https://hal-univ-lyon3.archives-ouvertes.fr/hal-00955752
Contributor : Widiane Ferchakhi <>
Submitted on : Monday, March 10, 2014 - 11:21:55 AM
Last modification on : Thursday, February 7, 2019 - 2:35:00 PM
Long-term archiving on : Tuesday, June 10, 2014 - 10:38:37 AM

File

FERCHAKHI_et_CEGARRA_2014.pdf
Publisher files allowed on an open archive

Identifiers

  • HAL Id : hal-00955752, version 1

Collections

Citation

Widiane Ferchakhi, Jean-Jack Cegarra. L'influence du capital marque sur le risque perçu de la substitution d'un médicament de marque par un médicament générique : proposition d'un modèle. 13TH INTERNATIONAL CONGRESS MARKETING TRENDS ISBN 978-2-9532811-2-7, Jan 2014, Venise, Italie. pp.12. ⟨hal-00955752⟩

Share

Metrics

Record views

356

Files downloads

1058